Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vericel Corp

VCEL Clue Score63
United States Fiscal year ends December CIK 0000887359 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

13 insiders · 0 transactions
16.1×

Dominick Colangelo holds 16.1 times base salary in stock. $13.91M of shares against $860.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dominick Colangelo last reported holding, valued at $44.53, the price Common Stock was last bought or sold at on the open market here, on 12 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Dominick Colangelo
President and CEO
—
—
—
312,446
$13.91M
+41.1%
Jonathan Mark Hopper
Chief Medical Officer
—
—
—
75,753
$3.37M
+27.8%
Alan L Rubino
Director
—
—
—
64,194
$2.86M
+169.8%
Heidi Hagen
Director
—
—
—
35,050
$1.56M
+22.3%
Robert L Md Zerbe
Director
—
—
—
32,995
$1.47M
+24.1%
Paul K Wotton
Director
—
—
—
18,802
$837.25K
−37.3%
Kevin F McLaughlin
Director
—
—
—
18,300
$814.90K
+53.8%
Michael Halpin
Chief Operating Officer
—
—
—
16,394
$730.02K
+119.7%
Joseph Anthony Mara Jr
Chief Financial Officer
—
—
—
16,009
$712.88K
+6.6%
Lisa Wright
Director
—
—
—
15,851
$705.85K
+67.7%
Karen Mahoney
Chief Human Resources Officer
—
—
—
1,854
$82.56K
—
Sean C. Flynn
Chief Legal Officer
—
—
—
1,647
$73.34K
0.0%
Jonathan Siegal
Principal Accounting Officer
—
—
—
1,078
$48.00K
−44.2%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.